Month: May 2020

news_6

ENHERTU® Demonstrated Meaningful Clinical Activity in Patients with HER2 Mutant Non-Small Cell Lung Cancer in Interim Analysis of Phase 2 DESTINY-Lung01 Trial

61.9% of patients with HER2 mutant metastatic non-small cell lung cancer treated with ENHERTU achieved a tumor response Breakthrough Therapy...

news_6

Takeda Receives Positive CHMP Opinion for Pre-Filled Syringe Presentation of TAKHZYRO® (lanadelumab) for Use as a Preventive Treatment for Hereditary Angioedema Attacks

Validation of Type II Variation will allow Takeda to commence launches in Europe later this year The pre-filled syringe presentation...

news_6

India Online Game Market Insights 2020: Smartphone Gaming, Regulations for Online Gaming, Future Outlook and Legal Framework – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "India Online Game Insights, Smartphone Gaming, Regulations for Online Gaming, Future Outlook and Legal Framework" report has been...

news_6

ENHERTU® Significantly Improved Tumor Response Rate and Overall Survival in HER2 Positive Metastatic Gastric Cancer in Pivotal Phase 2 DESTINY-Gastric01 Trial

First HER2 directed therapy to show an improvement in overall survival for previously-treated metastatic gastric cancer with a 41% reduction...